Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy (FREED)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01984749
Recruitment Status : Unknown
Verified August 2016 by Hisao Ogawa, Freed Study Group.
Recruitment status was:  Active, not recruiting
First Posted : November 15, 2013
Last Update Posted : August 26, 2016
Teijin Pharma Limited
Information provided by (Responsible Party):
Hisao Ogawa, Freed Study Group

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Estimated Primary Completion Date : October 2017
Study Completion Date : No date given
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 April 14, 2019
July 2, 2019
2 July 28, 2019
September 6, 2019
Publications automatically indexed to this study by Identifier (NCT Number):